Banner
Home Fascicolo n.6/1997 Bibliografia
Bibliografia
Attività a “scarto ridotto”
pubblicato nel Novembre - Dicembre 1997 in Sport&Medicina - fascicolo n.6

Bibliografia

1) Komaroff, A.L., Buchwald D.: Symptoms and signs of chronic fatigue syndrome. Review Infectious Diseases 13 (Suppl. 1): S8-11, 1991.

2) Wolfe F., Smythe H.A., Aeons M.B.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheumatology 33: 160-172, 1990.

3) Holmes G.P., Kaplan J.E., Schonberger L.B., et al.: Definition of the chronic fatigue syndrome. [Letter]. Annals Internal Medicine 109: 512, 1988.

4) McCully K., Sisto S.-A., Natelson B.: Use of exercise for treatment of chronic fatigue syndrome . Sports Med. 21: 35-48, 1996.

5) Bates D.W., Buchwald D., Lee J., Kith P., Doolittle T.H., Umali P., Komaroff A.L.: A comparison of case definitions of chronic fatigue syndrome . Clinical Infectious Diseases 18 (Suppl. 1): S11-S15, 1994.

6) Schluederberg A., Straus S.E., Peterson P., Blumenthal S., Komaroff A.L., Spring S.B., Landay A., Buchwald D.: Chronic fatigue syndrome research: definition and medical outcome assessment . Annals Internal Medicine 117: 325-331, 1992.

7) Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Komaroff A., Schluederberg A., Jones J.F., Lloyd A.R., Wessely S., Gantz N.G., Holmes G.P., Steele L., Reyes M., Abbey S., Rest J., Jolson H., Peterson D.L., Vercoulen J.H.M.M., Tirelli U., Evengard B., Natelson B.H., Reeves W.C.: Chronic Fatigue Syndrome: a comprehensive approach to its definition and study . Ann Intern Med. 121: 953-958, 1994.

8) Shorter E.: Chronic fatigue in historical perspective. In Chronic Fatigue Syndrome. Ciba Foundation Symposium 173. Wiley and Sons, Inc. Chichester England. pp 6-22, 1993.

9) Wessely S.: History of postviral fatigue syndrome . British Medical Bulletin 47: 919-941, 1991.

10) Anonymous. Chronic fatigue syndrome: Committe for Science and Education, Medical Association of South Africa . South African Med. J. 85: 780-782, 1995.

11) Edwards R.H.T., Gibson H., Clague J.E., Helliwell T.: Muscle histopathology and physiology in chronic fatigue syndrome . Chronic fatigue syndrome. Ciba foundation symposium, 173. Bock, G.R. and Whalan J., Eds. John Wiley & Sons, Chichester England. P102-131, 1993.

12) Conti, F., Priori R., et al.: Prevalence of chronic fatigue syndrome in Italian patients with persistant fatigue . Annali Italiani di Medicina Interna 9: 219-222, 1994.

13) Djaldetti R., Ziv I., et al.: Fatigue in multiple sclerosis compared with chronic fatigue syndrome: a quantitative assessment. Neurology 48: 632-635, 1996.

14) Kuratsune H., Yamaguti K., Takahashi M., Misaki H., Kitani T.: Summary report of 2nd meeting of The research committee on surveillance study of current CFS situations in Japan and pathogenesis and clinical features of CFS ”. March 8, 1993.

15) Lloyd A.R., Hickie I., Boughton C.R., Spencer O., Wakefield D.: Prevalence of chronic fatigue syndrome in an Australian population. Medical Journal Australia. 153: 522-528, 1990.

16) Natelson B.H., Ye N., Moul D.E., Jenkins F.J., Oren D.A., Tapp W.N., Cheng Y.-C.: High titers of anti-Epstein-Barr virus DNA polymerase are found in patients with severe fatiguing illness . Journal of Medical Virology 42: 42-46, 1994.

17) Blondel-Hill E., Shafran S.D.: Treatment of the chronic fatigue syndrome: a review and practical guide . Drugs 46: 639-651, 1993.

18) Buchwald, D., Pearlman T., et al.: Gender differences in patients with chronic fatigue syndrome. J. General Internal Medicine 9: 397-401, 1994.

19) Bates D.W., Schmitt W., Buchwald D., Ware N.C., Lee J., Thayer E., Kornish R.J.: Komaroff A.L., Prevalence of fatigue and chronic fatigue syndrome in a primary care practice . Archives of Internal Medicine 153: 2759-2765, 1993.

20) Jason L.A., Taylor R., et al.: Estimating rates of chronic fatigue syndrome from a community-based sample: a pilot study . Amer. J. Community Psychology 23: 557-568, 1995.

21) Lawrie, S.M., Pelosi A.J.: Chronic fatigue syndrome in the community. Prevalence and associations . Brit. J. Psychiatry 166: 793-797, 1995.

22) Buchwald D., Cheney P.R., Peterson D.L., Henry B., Wormsley H.B., Geiger A., Ablashi D.V., Salahuddin S.L., Saxinger C., Biddle R.: A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active herpes virus type 6 infection . Annals of Internal Medicine. 116: 103-113, 1992.

23) Keller R.H., Lane J.L., Klimas N., Reiter W.M., Fletcher M.A., van Riel F., Morgan R.: Association between HLA class II antigens and the chronic fatigue immune dysfunction syndrome. Clinical Infectious Diseases 18 (Suppl. 1): S154-S156, 1994.

24) Straus S.E., Dale J.K., Tobi M., Lawley T., Preble O., et al.: Acyclovir treatment of the chronic fatigue syndrome: lack of efficacy in a placebo-controlled trial . New England Journal of Medicine 26: 1692-1698, 1988.

25) Barker E., Fujimura S.F., Fadem M.B., Landay A.L., Levy J.A.: Immunologic abnormalities associated with chronic fatigue syndrome . Clinical Infectious diseases 18 (Suppl. 1): S136-S141, 1994.

26) Wessely S., Chalder T., Hirsch S., Pawlikowska T., Wallace P., Wright D.: Postinfectious fatigue: prospective cohort study in primary care. Lancet 345: 1333-1338, 1995.

27) Abbey S.E., Garfinkel P.E.: Chronic fatigue syndrome and depression: cause, effect, or covariate . Review of Infectious Diseases 13 (Suppl. 1): S73-S83, 1991.

28) Thase M.E.: Assessment of depression in patients with chronic fatigue syndrome . Reviews of Infectious Diseases 13 (Suppl. 1): S114-S118, 1991.

29) Grafman J., Johnson R., Scheffers M.: Cognitive and mood-state changes in patients with chronic fatigue syndrome . Reviews of Infectious Diseases 13 (Suppl. 1): S45-S50, 1991.

30) Cleare A.J., Bearn J., et al.: Contrasting neuroendocrine responses in depression and chronic fatigue syndrome . J Affective Disorders 34: 283-289, 1995.

31) MacDonald K.L., Osterholm M.T., et al.: A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. American J. Medicine 100: 548-554, 1996.

32) Van Houdenhove B., Onghena P., et al.: Does high ‘action-proneness’ make people more vulnerable to chronic fatigue syndrome? A controlled psychometric study. J. Psychosomatic Res. 39: 633-640, 1995.

33) Hickie, I., Lloyd A., et al.: Can the chronic fatigue syndrome be defined by distict clinical features? Psychological Med 25: 925-935, 1995.

34) Natelson B.H., Johnson S.K., et al.: Reducing heterogeneity in chronic fatigue syndrome: a comparison with depression and multiple sclerosis. Clinical Infectious Diseases 21: 1204-1210, 1995.

35) Calabrese L., Davis M.E., Wilke W.: Chronic fatigue syndrome and a disorder resembling Sjögren’s syndrome: preliminary report . Clinical Infectious Diseases 18 (Suppl. 1): S28-S31, 1994.

36) Komaroff A.L.: Clinic presentation of cronic fatigue syndrome . In: Chronic fatigue syndrome Ciba foundation symposium, 173. Bock, G.R. and Whalan J., Eds. John Wiley & Sons Chichester, England. pp. 43-61, 1993.

37) Boda, W.L., Natelson B.H., et al.: Gait abnormalities in chronic fatigue syndrome . J. Neurological Sci. 131: 156-161, 1995.

38) Noakes T.D.: Implications of exercise testing for prediction of athletic performance: a contemporary perspective . Med. Sci. Sports Exer. 1988. 20: 319-330.

39) Kent-Braun J., Sharma K.R., Weiner M.W., Masie B., Miller R.G.: Central basis of muscle fatigue in chronic fatigue syndrome . Neurology 43: 125-131, 1993.

40) Riley M.S., O’Brien C.J., McCluskey D.R., Bill N.P., Nicholls D.P.: Aerobic work capacity in patients with chronic fatigue syndrome. British Medical Journal. 301: 953-956, 1990.

41) Sisto S.A., LaManca J., et al.: Metabolic and cardiovascular effects of a progressive exercise test in patients with chronic fatigue syndrome . Am. J. Med. 100: 634-640, 1996.

42) Gibson H., Carroll N., Clague J.E., Edwards R.H.T.: Exercise performance and fatigability in patients with chronic fatigue syndrome. Journal Neurology Neurosurgery Psychiatry 56: 993-998, 1993.

43) Stokes M.J., Cooper R.G., Edwards R.H.T.: Normal muscle strength and fatigability in patient with effort syndromes . British Medical Journal 297: 1014-1017, 1988.

44) Montague T.J., Marrie T.J., Bewick D.J., Spencer C.A., Kornreich R., Horacek B.M.: Cardiac effects of common viral illnesses . Chest 94: 919-925, 1988.

45) Skinner J.S., Baldini F.D., Gardner A.W.: Assessment of fitness. In: Bouchard C., Shepard R.J., Stephens T., Sutton J.R., McPherson B.D., eds. Exercise, fitness, and health. Champaign IL, Human Kinetics, pp 109-120, 1990.

46) Lloyd A.R., Phales J., Gandevia S.C.: Muscle strength, endurance and recovery in the post-infection fatigue syndrome . Journal Neurology Neurosurgery Psychiatry 51: 1316-1322, 1988.

47) Lihdh M., Johansson G., Hedberg M., Henning G.-B., Grimby G.: Studies on maximal voluntary contraction in patients with fibromyalgia. Archives of Physical Medicine and Rehabilitation 75: 1217-1222, 1994.

48) Wong R., Lopachuk G., Zhu G., Walker D., Catellier D., Burton D., Teo K., Collins-Nakai R., Montague T.: Skeletal muscle metabolism in the chronic fatigue syndrome: In vivo assessment by 31P nuclear magnetic resonance spectroscopy. Chest 102: 1716-1722, 1992.

49) Evans W.J., Phinney S.D., et al.: Suction applied to a muscle biopsy maximises sample size . Med. Sci. Sports Exerc. 14: 101-102, 1982.

50) Barbiroli B., McCully K., et al.: Further impairments of muscle phosphate kinetics by lengthening exercise in BMD/DMD carriers . J. Neurol. Sci. 119: 65-73, 1993.

51) Barnes P.R.J., Taylor D.J., Kemp G.J., Radda G.K.: Skeletal muscle bioenergetics in the chronic fatigue syndrome . Journal Neurological Neurosurgery and Psychiatry 56: 679-683, 1993.

52) McCully K., Natelson B., Sisto S.-A., Iotti S., Posner J., Leigh J.: Reduced oxidative muscle metabolism in chronic fatigue syndrome . Muscle Nerve 19: 621-625, 1996.

53) Behan W.M.H., More I.A.R., Behan P.O.: Mitochondrial abnormalities in the postviral fatigue syndrome . Acta Neuropathology. 83: 61-65, 1991.

54) Byrne E., Trounce I., Dennett X.: Chronic relapsing myalgia (? post viral): clinical histological, and biochemical studies . Aust NZ Journal Medicine 15:305-308, 1985.

55) Byrne E., Trounce I.: Chronic fatigue and myalgia syndrome: mitochondrial and glycolytic studies in skeletal muscle . Journal Neurology Neurosurgery Psychiatry 50: 743-746, 1987.

56) Plioplys A.V., Plioplys S.: Electron-microscopic investigation of muscle mitochondria in chronic fatigue syndrome . Neuropsycholobiology 32: 175-181, 1995.

57) Wassif W.S., Sherman D., et al.: Use of dynamic tests of muscle function and histomorphometry of quadriceps muscle biopsies in the investigation of patients with chronic alcohol misuse and chronic fatigue syndrome. Ann. Clin. Biochem. 31: 462-468, 1994.

58) Arnold D.L., Radda G.K., Bore P.J., Styles P., Taylor D.J.: Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome . Lancet June 1367-1369, 1984.

59) Bennett R.M.: Muscle physiology and cold reactivity in the fibromyalgia syndrome . Rheum Dis. Clin. North. Am. 15: 135-147, 1989.

60) Lihdh M., Johansson G., Hedberg M., Henning G.-B., Grimby G.: Muscle fiber characteristics, capillaries and enzymes in patients with fibromyalgia and controls . Scandinavian Journal Rheumatology 24: 34-37, 1995.

61) Bennett R.M., Clark S.R., Campbell S.M., Ingram S.B., Burchardt C.S., Nelson D.L., Porter J.M.: Symptoms of Raynaud’s syndrome in patients with fibromyalgia . Arthritis and Rheumatism 34: 264-269, 1991.

62) McCully K.K., Kakihira H., Vandenborne K., Kent-Braun J.A.: Noninvasive measurements of activity-induced changes in muscle metabolism . J Biomech 24: (Suppl.) 153-162, 1991.

63) Kent-Braun J., Sharma K.R., Miller R.G., Weiner M.W.: Postexercise phosphocreatine resynthesis is slowed in multiple sclerosis . Muscle Nerve 17: 835-841, 1994.

64) Armstrong R.B.: Mechanisms of exercise-induced delayed onset muscular soreness: a brief review . Medicine Science Sports Exercise 16: 529-538, 1984.

65) Jubrias S.A., Bennett R.M., Klug G.A.: Increased incidence of a resonance in the phosphodiester region of 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyaglia patients . Athritis & Rheum. 37:801-807, 1994.

66) Sisto S.A.: Chronic fatigue syndrome: an overview and intervention guidelines . Neurology. Report 17: 30-34, 1993.

67) Newsholme E.A., Parry-Billings M.: Effects of exercise on the immune system . In: Physical Activity, Fitness, and Health . Eds: Bouchard C., Shepard R.J., Stephens T., Human Kinetics Publishers, Champaign IL pp 451-455, 1994.

68) Lloyd A.R., Gandevia S., Brockman A., Hales J., Wakefield D.: Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise . Clinical Infectious Diseases 18(Suppl. 1): S142-S146, 1994.

69) Lutgendorf S.K., Antoni M.H., et al.: Physical symptoms of chronic fatigue syndrome are exacerbated by the stress of Hurricane Andrew. Psychosomatic Med. 57: 310-323, 1995.

70) Gantz N.M., Holmes G.P.: Treatment of patients with chronic fatigue syndrome . Drugs 38: 855-862, 1989.

71) Goldman J.A.: Hypermobilty and deconditioning: important links to fibromyalgia/fibrositis. Southern Medical Journal 84: 1192, 1991.

72) McCain G.A., Bell D.A., Mai F.M., Halliday P.D.: A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia . Arthritis Rheumatology 31: 1135, 1988.

73) Clark M.R., Katon W., et al.: Chronic fatigue: risk factors for symptom persistence in a 2 1/2- year follow-up study. Amer. J. Med. 98: 187-195, 1995.

74) Wilson A., Hickie I., Lloyd A., Hadzi-Pavlovic D., Boughton C., Dwyer J., et al.: Longitudinal study of outcome of chronic fatigue syndrome . British Medical Journal 308: 756-759, 1994.

75) Kroenke K., Wood D.O., Mangelsdorff A.D.: Chronic fatigue in primary care: prevalence, patient characteristics, and outcome . Journal American Medical Association 260: 929-934, 1988.

76) Hyde B., Bergmann S.: Akureyri disease (myalgic encephalomyelitis), forty years later. Lancet (letter) November 19, 1190-1191, 1988.

77) Schweitzer R., Kelly B., et al.: Quality of life in chronic fatigue syndrome . Social Sci and Med 41: 1367-1372, 1995.

78) Deluca J., Johnson S.K., Beldowics D., Natelson B.H.: Neuropsychologic impairments in chronic fatigue syndrome, multiple sclerosis, and depression . Journal of Neurology, Neurosurgery, and Psychiatry 58: 38-43, 1995.